The Australian High Court yesterday extended a ban on selling Samsung’s Galaxy 10.1 tablet for at least another week, despite a lower court allowing the device to compete in stores with Apple’s iPad.
The Australian case is one of several patent tussles going on around the world between Samsung and Apple as they seek to dominate the US$100 billion market for tablet computers and smartphones.
The Federal Court in Sydney on Wednesday lifted a temporary ban on the sale of the Samsung Galaxy Tab 10.1, pending a full hearing into whether the device copies the iPad.
However, Apple immediately won a stay of orders and requested the High Court prolong the injunction.
A spokeswoman for the High Court said Justice Dyson Heydon had expedited the matter into the special leave list in Sydney set for Friday.
“He also extended the stay — which prevents Samsung from selling its Galaxy tablet — until the determination of the application for special leave to appeal,” she said.
The South Korean electronics giant has previously said, through its Australian lawyer, that any extension of the ban “simply serves to prolong the injustice suffered by Samsung.”
However, Apple claims the Galaxy Tab 10.1, which has not yet been sold in Australia, infringes 13 of its patents.
The temporary injunction was initially granted in October on a finding that Apple had established a prima facie case that the device breached two patents related to touchscreen technology.
It was overturned by a full bench federal court that said that further delaying the sale of the Galaxy would effectively “kill off” the device.
The date for the full hearing has not been set.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained